文献库搜索 | GeneLibs

Ma(X),Shi(Q),Dong(Z),Chen(C),Zhu(J),Liu(X)... Animals (Basel) 2026-01-14

...Pik3ca, Bcl2l11, Gadd45a, Pmaip1, Ddit3, and Fos), and the p53 signaling pathway (Serpine1, Sesn2, Ccng2, Igf1, Mdm2, Ga...

Zong(Z),Zhou(X),Shen(J),Yan(M),Xia(X),Li(J... Cancers (Basel) 2026-01-19

...PIK3CA mRNA levels predicted inferior survival in external cohorts. p110α protein expression is an independent biomarker...

Leyva(A),Khan Niazi(MK) Genes (Basel) 2026-01-02

...PIK3CA in oncogenesis, where TP53 is inhibited through disruptive loss-of-function mutations, whereas PIK3CA is recurren...

Ochman(B),Limanówka(P),Mielcarska(S),Kula(... Int J Mol Sci 2026-01-17

...PIK3CA/AKT1 mutations (n = 104). Both TIGIT and CD155 were significantly elevated in tumor tissue versus margins (p < 0....

Pirola(M),Molinaro(E),Manfredini(S),Cuoghi... Int J Mol Sci 2026-01-22

...PIK3CA mutations were observed. Patients experiencing relapse more than six months after diagnosis were more likely to h...

Toromani(G),Saglimbeni(GS),Upadhyayula(BS)... Medicina (Kaunas) 2026-01-07

...PIK3CA (25.5%), TP53 (21.6%), ARID1A (20.6%), and KRAS (16.7%). Significant amplification of ERBB2 was also observed (n ...

Chen(H),Huang(Z),Chang(R),Gao(W),Qiu(Y),Su... Adv Sci (Weinh) 2026-04-00

PIK3CA mutations drive benign adipose overgrowth in facial infiltrating lipomatosis (FIL), but the downstream molecular ...

Mitsui(A),Esaki(M),Nara(S),Arai(Y),Nakamur... J Pathol 2026-05-00

...PIK3CA, MUC17, MAP3K4, MUC2, BRAF, NF1). Genetic landscapes were similar in SDT iCCA with and without BDTT; recurrent mu...

Park(MS),Youn(Y),Kim(JA),Cho(EH),Do(IG),Wo... Breast Cancer 2026-03-00

...PIK3CA mutations were the second most common, detected in 11.6%, 4.5%, and 5.8% of patients, respectively. ctDNA positiv...

Li(S),Liu(L),Gandhi(N),Farrell(A),Lou(E),S... Oncologist 2026-02-05

...PIK3CA mutations and dMMR/MSI-H were increased in females. Our study queries one of the largest datasets of GI- and P-NE...